Continuum Advisory’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.8K Buy
+30
New +$16.8K ﹤0.01% 1119
2025
Q2
Sell
-23
Closed -$9.66K 943
2025
Q1
$9.66K Sell
23
-2
-8% -$868 ﹤0.01% 985
2024
Q4
$10.3K Buy
25
+2
+9% +$877 ﹤0.01% 977
2024
Q3
$9.74K Buy
23
+2
+10% +$972 ﹤0.01% 998
2024
Q2
$10.2K Buy
21
+1
+5% +$502 ﹤0.01% 940
2024
Q1
$10K Buy
+20
New +$10.9K ﹤0.01% 934

Other funds holding IDXX

Continuum Advisory's IDXX Position: Q2 2026 in Review

Continuum Advisory opened a new position in Idexx Laboratories (IDXX) in Q2 2026: 30 shares worth $15.8K. The stake represents ﹤0.01% of the portfolio and ranks #1119 among its holdings. This is a return to the name: Continuum Advisory previously reported a position in IDXX as recently as Q1 2025.

Continuum Advisory first reported a position in IDXX in Q1 2024 and has held it in 6 quarters since. 1,305 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Continuum Advisory held 30 shares of Idexx Laboratories worth $15.8K as of Q2 2026.
  • Idexx Laboratories was a new Continuum Advisory position in Q2 2026.
  • Idexx Laboratories made up ﹤0.01% of Continuum Advisory's portfolio in Q2 2026, its #1119 holding.
  • Continuum Advisory first reported a position in Idexx Laboratories in Q1 2024 and has held it in 6 quarters since.
  • 1,305 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Continuum Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.